hemotune AG is developping a revolutionary medical device for blood purification that combines cutting-edge scientific results from biomedicine and nanotechnology. It allows specific and direct removal of disease-causing substances from the blood stream of a patient. The technology targets a broad range of harmful compounds such as toxins, pathogenic organisms, or overdosed drugs. Moreover, by being more targeted, efficient, and gentler than previous blood filters, we outperform state of the art therapies and improve patient outcomes.
Our first development candidate focuses on sepsis, a blood spread infection with so far only very limited treatment options.
Executive hires to help startups scale (startupticker.ch)
Hemotune secures CHF 14 Million in Series B2 Funding to advance innovative blood purification technology (venturelab.swiss)
CHF 14 million to fund hemotune’s clinical trials (startupticker.ch)
How Zühlke and Venturelab create a win-win ecosystem for startups (venturelab.swiss)
Swiss Accelerator: Innosuisse supports 53 companies with CHF112 million (startupticker.ch)
AstraZeneca enters close collaboration with hemotune (startupticker.ch)
hemotune initiates joint feasibility project on the HemoSystem with AstraZeneca (venturelab.swiss)
The 16 most promising medtech startups in 2022, according to investors (TOP 100)
Swiss startups get global exposure (startupticker.ch)
Innovative technologies for Europe lie in Switzerland (startupticker.ch)
CHF 7.25 million for a platform reducing the burden of sepsis (startupticker.ch)
hemotune raises CHF 7.25 million Series B1 funding for the development of their disruptive blood purification platform (venturelab.swiss)
Swiss Economic Award: Das sind die Finalisten (startupticker.ch)
Fourteen Swiss startups ready for scaling (startupticker.ch)
TOP 100 Lighthouse Event Zurich: 6 TOP 100 Swiss Startups pitch to Credit Suisse investors (TOP 100)
Venture Leaders Life Sciences and Medtech pitch to an audience of international investors, VCs and experts in Harvard, Cambridge (venturelab.swiss)
Joint roadshow in Boston for Venture Leaders Life Sciences 2020 and Medtech 2021 (venturelab.swiss)
The Venture Leaders Medtech 2021 kick off their roadshow to connect with international investors (venturelab.swiss)
Meet hemotune co-founder Lukas Langenegger and find out how he develops breakthrough blood purification technology (venturelab.swiss)
First Venture Leaders Medtech selected (startupticker.ch)
hemotune - Restoring immune balance in sepsis